Minimally invasive laser-based procedure restores blood flow in complex arterial blockage, enables next-day discharge and improved mobility
Growth was broad-based across segments
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
Pharma giant targets new standards of care
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
Subscribe To Our Newsletter & Stay Updated
